Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

A container with vaccine bottles lined up next to each other

Monday Morning Vaccine Breakthrough: Terrific News for the West, but in LMICs Terms and Conditions Apply

This morning, America (and much of the world) woke up to a snippet of terrific news: Pfizer and BioNTech announced their SARS-CoV2 vaccine candidate showed 90 percent efficacy. But for policymakers in low- and middle-income countries, today’s news offers limited cause for celebration—and the Pfizer/BioNTech results may even lengthen the timeline for eventual LMIC access.

Pages